North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Cetuximab
found
9 matches
Open monograph to display formulary status
BNF Category
Cetuximab
Malignant disease and immunosuppression - Cetuximab - 08.01.05
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update (Feb 2014): Cetuximab: new safety information available (08.01.05)
NICE TA145: Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck (08.01.05)
NICE TA242: Cetuximab for the treatment of metastatic colorectal cancer after first-line chemotherapy: monotherapy or combination chemotherapy (08.01.05)
NICE TA439 Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (08.01.05)
NICE TA439 Cetuximab and panitumumab for previously untreated metastatic colorectal cancer (08.01.05)
NICE TA473 Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck (oral cavity) (08.01.05)
NICE TA668: Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer (08.01.05)
SubSection Titles / notes
Cetuximab
- (08.01.05)